Literature DB >> 23001194

Cysteine-rich matricellular protein improves callus regenerate in a rabbit trauma model.

Soenke Percy Frey1, Stefanie Doht, Lars Eden, Stefan Dannigkeit, Norbert Schuetze, Rainer H Meffert, Hendrik Jansen.   

Abstract

PURPOSE: Open fractures with severe soft-tissue trauma are predisposed to poor bone healing. The vital coupling between osteo- and angiogenesis is disturbed. Cysteine-rich protein 61 (CYR61) is an angiogenic inducer promoting vascularisation. However, little is known about the effect of CYR61 on the callus regenerate after acute musculoskeletal trauma. Therefore, our aim was to determine whether local administration of CYR61: (1) has an influence on callus formation and remodelling, (2) increases bone volume and (3) partially restores callus stability.
METHODS: A musculoskeletal trauma was created in 20 rabbits. To simulate fracture-site debridement, the limb was shortened. In the test group, a CYR61-coated collagen matrix was locally applied around the osteotomy. After ten days, gradual distraction was commenced (0.5 mm/12 h) to restore the original length. New bone formation was evaluated histomorphometrically, radiographically and biomechanically.
RESULTS: Osseus consolidation occured in all animals. Average maximum callus diameter was higher in the test group [1.39 mm; standard deviation (SD) = 0.078 vs 1.26 mm (SD = 0.14); p = 0.096]. In addition, bone volume was higher (p = 0.11) in the test group, with a mean value of 49.73 % (SD = 13.68) compared with 37.6 % (SD = 5.91). Torsional strength was significantly higher (p = 0.005) in the test group [105.43 % (SD = 31.68 %) vs. 52.57 % (SD = 24.39)]. Instead, stiffness of the newly reconstructed callus decreased (64.21 % (SD = 11.52) vs. 71.30 % (SD = 32.25) (p = 0.81)).
CONCLUSIONS: CYR61 positively influences callus regenerate after acute trauma, not only histologically and radiographically but also biomechanically, most probably by a CYR61-associated pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23001194      PMCID: PMC3479291          DOI: 10.1007/s00264-012-1659-6

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  31 in total

1.  Effect of vascularity on canine distracted tibial callus consolidation.

Authors:  Satoru Ohashi; Isao Ohnishi; T Kageyama; S Fukuda; A Tsuchiya; Kazuhiro Imai; J Matsuyama; Kozo Nakamura
Journal:  Clin Orthop Relat Res       Date:  2005-09       Impact factor: 4.176

2.  The influence of soft tissue trauma on bone regeneration after acute limb shortening.

Authors:  Rainer H Meffert; Hendrik Jansen; Sönke P Frey; Michael J Raschke; Martin Langer
Journal:  Clin Orthop Relat Res       Date:  2007-07       Impact factor: 4.176

Review 3.  Mechanical regulation of the Cyr61/CCN1 and CTGF/CCN2 proteins.

Authors:  Brahim Chaqour; Margarete Goppelt-Struebe
Journal:  FEBS J       Date:  2006-07-19       Impact factor: 5.542

4.  Expression, purification, and functional testing of recombinant CYR61/CCN1.

Authors:  Norbert Schütze; Karin Kunzi-Rapp; Rita Wagemanns; Ulrich Nöth; Susanne Jatzke; Franz Jakob
Journal:  Protein Expr Purif       Date:  2005-07       Impact factor: 1.650

5.  The matricellular protein CYR61 inhibits osteoclastogenesis by a mechanism independent of alphavbeta3 and alphavbeta5.

Authors:  Julie C Crockett; Norbert Schütze; Denise Tosh; Susanne Jatzke; Angela Duthie; Franz Jakob; Michael J Rogers
Journal:  Endocrinology       Date:  2007-09-06       Impact factor: 4.736

6.  Axial shortening during distraction osteogenesis leads to enhanced bone formation in a rabbit model through the HIF-1alpha/vascular endothelial growth factor system.

Authors:  Shigeshi Mori; Masao Akagi; Aiichiro Kikuyama; Yoshiko Yasuda; Chiaki Hamanishi
Journal:  J Orthop Res       Date:  2006-04       Impact factor: 3.494

7.  Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective tissue growth factor angiogenic inhibitory complexes by MMP-2 proteolysis.

Authors:  Richard A Dean; Georgina S Butler; Yamina Hamma-Kourbali; Jean Delbé; David R Brigstock; José Courty; Christopher M Overall
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 4.272

8.  Vascular endothelial growth factor (VEGF)-induced up-regulation of CCN1 in osteoblasts mediates proangiogenic activities in endothelial cells and promotes fracture healing.

Authors:  Athanasios N Athanasopoulos; Darius Schneider; Tanja Keiper; Volker Alt; Usha R Pendurthi; Ute M Liegibel; Ulrike Sommer; Peter P Nawroth; Christian Kasperk; Triantafyllos Chavakis
Journal:  J Biol Chem       Date:  2007-07-10       Impact factor: 5.157

9.  The angiogenic factor CCN1 promotes adhesion and migration of circulating CD34+ progenitor cells: potential role in angiogenesis and endothelial regeneration.

Authors:  Karsten Grote; Gustavo Salguero; Matthias Ballmaier; Marc Dangers; Helmut Drexler; Bernhard Schieffer
Journal:  Blood       Date:  2007-04-11       Impact factor: 22.113

Review 10.  Biological mechanisms of bone and cartilage remodelling--genomic perspective.

Authors:  F Borovecki; N Pecina-Slaus; S Vukicevic
Journal:  Int Orthop       Date:  2007-07-03       Impact factor: 3.075

View more
  4 in total

Review 1.  The matricellular protein CCN1 in tissue injury repair.

Authors:  Ki-Hyun Kim; Jong Hoon Won; Naiyuan Cheng; Lester F Lau
Journal:  J Cell Commun Signal       Date:  2018-01-22       Impact factor: 5.782

2.  Sclareol inhibits RANKL-induced osteoclastogenesis and promotes osteoblastogenesis through promoting CCN1 expression via repressing the MAPK pathway.

Authors:  Xiang Li; Yuxin Wang; Liangping Li; Shengji Zhou; Fengchao Zhao
Journal:  Cell Biol Toxicol       Date:  2021-01-09       Impact factor: 6.691

3.  CYR61/CCN1 Regulates Sclerostin Levels and Bone Maintenance.

Authors:  Gexin Zhao; Bau-Lin Huang; Diana Rigueur; Weiguang Wang; Chimay Bhoot; Kemberly R Charles; Jongseung Baek; Subburaman Mohan; Jie Jiang; Karen M Lyons
Journal:  J Bone Miner Res       Date:  2018-03-05       Impact factor: 6.390

4.  The Role of Genetically Modified Mesenchymal Stem Cells in Urinary Bladder Regeneration.

Authors:  Devon C Snow-Lisy; Edward C Diaz; Matthew I Bury; Natalie J Fuller; Jessica H Hannick; Nida Ahmad; Arun K Sharma
Journal:  PLoS One       Date:  2015-09-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.